These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27593477)

  • 1. Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts.
    Chen R; Sjoberg DD; Huang Y; Xie L; Zhou L; He D; Vickers AJ; Sun Y; ;
    J Urol; 2017 Jan; 197(1):90-96. PubMed ID: 27593477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial variations in the performance of prostate specific antigen and prostate specific antigen density in the era of extended prostate biopsy schemes.
    Elliott CS; Shinghal R; Presti JC
    J Urol; 2008 Oct; 180(4):1318-23; discussion 1323-4. PubMed ID: 18707710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy.
    Chen R; Xie L; Xue W; Ye Z; Ma L; Gao X; Ren S; Wang F; Zhao L; Xu C; Sun Y;
    Urol Oncol; 2016 Sep; 34(9):416.e1-7. PubMed ID: 27185342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1).
    Chen R; Zhou LQ; Cai XB; Xie LP; Huang YR; He DL; Gao X; Xu CL; Ding Q; Wei Q; Yin CJ; Ren SC; Wang FB; Tian Y; Sun ZQ; Fu Q; Ma LL; Zheng JH; Ye ZQ; Ye DW; Xu DF; Hou JQ; Xu KX; Yuan JL; Gao X; Liu CX; Pan TJ; Sun YH;
    Asian J Androl; 2015; 17(6):1017-21. PubMed ID: 25926603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population.
    He D; Wang M; Chen X; Gao Z; He H; Zhau HE; Wang W; Chung LW; Nan X
    Urology; 2004 Apr; 63(4):722-6. PubMed ID: 15072888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.
    Palmerola R; Smith P; Elliot V; Reese CT; Mahon FB; Harpster LE; Icitovic N; Raman JD
    Can J Urol; 2012 Dec; 19(6):6542-7. PubMed ID: 23228289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percent free prostate-specific antigen does not improve the effectiveness of prostate cancer detection in Chinese men with a prostate-specific antigen of 2.5-20.0 ng/ml: a multicenter study.
    Huang M; Lin Y; Xu A; Uhlman M; Deng X; Lin X; Wu S; Diao P; Xie K; Tang P
    Med Oncol; 2014 Apr; 31(4):925. PubMed ID: 24659324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0 ng/mL equivalent to that in men with 4.1 to 10.0 ng/mL in a Japanese population.
    Kobayashi T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    Urology; 2004 Apr; 63(4):727-31. PubMed ID: 15072889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
    Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
    Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?
    Teoh JY; Yuen SK; Tsu JH; Wong CK; Ho BSh; Ng AT; Ma WK; Ho KL; Yiu MK
    Asian J Androl; 2015; 17(5):821-5. PubMed ID: 25652619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA.
    Zhao J; Liu S; Gao D; Ding S; Niu Z; Zhang H; Huang Z; Qiu J; Li Q; Li N; Xie F; Cui J; Lu J
    Oncotarget; 2017 Feb; 8(6):9935-9946. PubMed ID: 28039477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index influences prostate cancer risk at biopsy in Japanese men.
    Masuda H; Kagawa M; Kawakami S; Numao N; Matsuoka Y; Yokoyama M; Yamamoto S; Yonese J; Fukui I; Kihara K
    Int J Urol; 2013 Jul; 20(7):701-7. PubMed ID: 23186107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection rate in Indonesian men.
    Mochtar CA; Atmoko W; Umbas R; Hamid ARAH
    Asian J Surg; 2018 Mar; 41(2):163-169. PubMed ID: 28209461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Maori and Pacific Islander men present with more advanced prostate cancer than European New Zealand men? An analysis of 486 men undergoing biopsy in Auckland.
    Pokorny MR; Scott DJ
    BJU Int; 2011 Apr; 107 Suppl 3():27-32. PubMed ID: 21492373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen <10 ng/mL and non-suspicious digital rectal examination.
    Ito M; Masuda H; Kawakami S; Fujii Y; Koga F; Saito K; Yamamoto S; Yonese J; Fukui I; Kihara K
    Int J Urol; 2013 Dec; 20(12):1163-8. PubMed ID: 23521022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases.
    Jia Y; Zhu LY; Xian YX; Sun XQ; Gao JG; Zhang XH; Hou SC; Zhang CC; Liu ZX
    World J Surg Oncol; 2017 Aug; 15(1):165. PubMed ID: 28851376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
    Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
    Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men.
    Lam JS; Cheung YK; Benson MC; Goluboff ET
    J Urol; 2003 Aug; 170(2 Pt 1):451-6. PubMed ID: 12853797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.